Origin Agritech (Nasdaq: SEED) announced a licensing agreement with a multinational partner to develop high-yielding corn varieties incorporating the Origin Agritech glyphosate- resistant and Bt- traits. These particular traits have been demonstrated to be effective in both lab and field environments, are novel to the markets in China in that it has never been commercialized, and are protected by patents granted separately by China and USA. Origin will license the traits to its partner and take the lead in the development and testing activities.
Origin Agritech possesses comprehensive, worldwide rights to the Chinese Academy of Agricultural Sciences- (CAAS) developed glyphosate- resistant and BT- genes. These traits have been passing through the Ministry of Agriculture (MoA) regulatory trials since 2005.
“This agreement marks a milestone for Origin Agritech to validate our GM technology. After the successful integration of these traits, we would be looking to finalize subsequent collaboration agreements to sell these seeds into China as well as other markets potentially, “said Irving Kau, Acting Chief Financial Officer of Origin. “We look forward to bringing together the significant research communities of both companies to deliver the next generation of technology.”
Since their introduction in 1996, over 75 million acres of genetically engineered glyphosate-resistant crops have been planted. The adoption of glyphosate-resistant crops has reduced costs for US farmers an estimated $1.2 Billion. Introduced in the US in 1998, the use of glyphosate resistant corn grew from 950,000 acres in 1999 to 41 million acres by 2007, or at a compounded annual growth rate of 51.9%, according to the US Department of Agriculture.Introduced in 1996 in the US, acreage of BT corn has grown from 3.6 million acres in 1999 to 44 million acres by 2007, or at a compounded annual growth rate of 36.7%, according to the US Department of Agriculture.
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts